| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |